News
Dr. Reddy's Launches Drug-Free Migraine Management Device Nerivio In Europe Following Successful Launch In India
10 Apr 24
Government, News, Regulations
Dr. Reddy's Laboratories Ltd. And Bayer Entered Into A Partnership To Market And Distribute A Second Brand Of Vericiguat In India. Under The Terms Of This Agreement, Bayer Has Granted Non-Exclusive Rights To Dr. Reddy's Under The Brand Name Gantra
5 Apr 24
News, Contracts, Global
Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand
22 Feb 24
Biotech, Large Cap, News, Health Care, General
Dr Reddy's Laboratories: Q3 Earnings Insights
30 Jan 24
Earnings
Dr Reddy's Laboratories Q3 EPS $0.99 Beats $0.79 Estimate, Sales $866.64M Beat $825.86M Estimate
30 Jan 24
Earnings, News
Barclays Maintains Overweight on Dr Reddy's Laboratories, Raises Price Target to $80
29 Jan 24
News, Price Target, Analyst Ratings
Press releases
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
22 Mar 24
Health Care, Press Releases
Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
19 Mar 24
Press Releases
Dr. Reddy's Q3 & 9M FY24 Financial Results
31 Jan 24
Press Releases